Insulin Lispro
Pricing Report NDC 66733-773-01

Latest NADAC: $7.91329 per ML · Effective Dec 21, 2022 · Est. package price $79.13 (10 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Insulin Lispro (NDC 66733-773-01) is $7.91329 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 21, 2022.

As a provided by Imclone Llc, this medication is distributed in a 1 VIAL in 1 CARTON / 10 mL in 1 VIAL configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$7.91329
Per ML

Effective Date
Dec 21, 2022
Billable Units
10 ML
Estimated Package Price
$79.13
Data Status
As of Dec 28, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 VIAL in 1 CARTON / 10 mL in 1 VIAL
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2019, the NADAC wholesale price for (NDC ) has moved within a range of $7.89197 to $13.20979 per ML. Over this 3 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$7.8920 - $13.2098
Market Volatility
67.38% Variance
Latest Trend
0.06%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Dec 21, 2022 $7.91329 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $7.90854 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $7.89516 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $7.90560 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2022 $7.91538 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2022 $7.90160 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 22, 2022 $7.89197 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 18, 2022 $7.90541 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 20, 2022 $7.90582 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 23, 2022 $7.91897 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 12, 2022 $7.90503 MLC/I - Chain or Independent PharmacyCode 3, 5, 6G - Generic
Jan 12, 2022 $7.90503 MLC/I - Chain or Independent PharmacyCode 4, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026